against a concentration gradient. After their secretion into the canaliculus, bile salts are prevented from regurgitation into the systemic circulation by hepatocyte tight junctions, the integrity of which is disturbed during bile duct obstruction. 1 The total bile salt pool size in adult humans amounts to 50-60 mol/kg body weight, corresponding to 3-4 g, and is largely stored in the gallbladder during the fasting state. Rats, in contrast, lack this reservoir function because of absence of a gallbladder. The human bile salt pool circulates 6 to 10 times per 24 hours, resulting in a daily bile salt secretion of 20-40 g. Despite a high degree of intestinal bile salt conservation, about 0.5 g of bile salts are lost through fecal excretion. This loss is compensated for by de novo hepatic bile salt synthesis, which contributes less than 3% of bile salts secreted with hepatic bile. 2 The intrinsic link between intestinal bile salt absorption and hepatic synthesis has recently been delineated by the discovery that hydrophobic bile salts can upregulate the ileal bile acid binding protein and downregulate hepatic cholesterol 7␣-hydroxylase through the action of a nuclear bile salt receptor on gene transcription. 3 By this mechanism, bile salts can regulate their own enterohepatic circulation.
In addition to hepatic synthesis and ileal absorption, uptake from sinusoidal blood and in particular secretion of bile salts across the canalicular hepatocyte membrane are the major determinants governing the rate of bile secretion. Disturbances of bile salt transport across the basolateral and apical domains of the hepatocyte plasma membrane are important causes of acquired and genetic forms of cholestatic liver disease, as discussed elsewhere in this issue. The consequences of defective bile salt secretion are not only progressive liver damage, but also metabolic derangements and malnutrition secondary to reduced intestinal absorption of lipids and fat-soluble vitamins. This article summarizes the most recent developments in the molecular physiology of hepatic bile salt transport.
SINUSOIDAL BILE SALT TRANSPORT
The specific architecture of the liver sinusoids allows the passage of protein-bound compounds through endothelial fenestrae into the space of Disse, where the sinusoidal uptake systems of the hepatocyte membrane can extract molecules from albumin. 1 A wide spectrum of lipophilic endogenous and exogenous compounds is taken up efficiently by specialized transport proteins localized in the basolateral (sinusoidal and lateral) hepatocyte membrane. The first-pass extraction of conjugated bile salts from sinusoidal blood ranges from 75% to 90% depending on bile salt structure but remains constant irrespective of systemic bile salt concentrations. 4, 5 Under physiologic conditions, uptake occurs predominantly into periportal hepatocytes, resulting in a lobular concentration gradient between zone 1 (periportal) and zone 3 (perivenous) hepatocytes. 6 Under pathophysiologic conditions such as cholestasis, the transport polarity of the hepatocyte may be reversed, which together with the disturbed tight junctional integrity results in the overspill of bile salts into the systemic circulation. Conceptually, physiologic basolateral uptake of bile salts must therefore be separated from basolateral bile salt efflux under cholestatic conditions.
Basolateral Bile Salt Uptake
The Na + -dependent portion of bile salt uptake is driven by the transmembrane Na + gradient that is maintained by Na + -K + -ATPase and is therefore unidirectional. The Na + -independent portion is largely mediated by facilitated exchange with intracellular anions such as glutathione.
Sodium-dependent Bile Salt Uptake
Bile salts are taken up into hepatocytes by sodiumdependent and sodium-independent mechanisms. 7, 8 The sodium-dependent pathway accounts for more than 80% of taurocholate uptake but for less than 50% of cholate uptake. [9] [10] [11] [12] [13] [14] [15] It has been characterized in detail in experimental models such as the isolated perfused rat liver, 16 isolated hepatocyte cultures, and basolateral plasma membrane vesicles. [17] [18] [19] Although unconjugated bile salts are uncharged molecules with pK a values of 5.0-6.0 that can traverse membranes also by passive nonionic diffusion, conjugation with glycine or taurine decreases their pK a values <2.0-4.0, necessitating the presence of a transport protein for cellular uptake. 5 Thus, whereas uptake of conjugated bile salts is electrogenic and involves cotransport of two Na + ions with one taurocholate molecule, unconjugated bile salts do not lead to Na + -dependent depolarization in short-term cultured hepatocytes. 20, 21 Expression and molecular cloning strategies have resulted in the isolation of the main sodium-dependent bile salt transporter, the Na + -taurocholate cotransporting polypeptide from rat (Ntcp), human (NTCP), mouse (Ntcp1, Ntcp2) and rabbit liver. [22] [23] [24] [25] Rat Ntcp (gene symbol Slc10a1) consists of 362 amino acids with an apparent molecular mass of 51 kDa. 26, 27 It is expressed exclusively in hepatocytes and is localized strictly at the basolateral membrane (Fig. 1) . 26 Ntcp is unique among the sodium cotransporters in that it possesses only seven membrane-spanning domains. 28 The C-terminal end is localized intracellularly. 26 Ntcp mediates sodiumdependent uptake of taurocholate and other bile salts At the basolateral membrane, the chief uptake systems for conjugated bile salts are the Na + -taurocholate cotransporting polypeptides Ntcp (rat) and NTCP (human). In rat liver, Na + -independent transport accounts for less than 20% of taurocholate uptake but more than 50% of cholate uptake and is largely mediated by the multispecific organic anion transporting polypeptides Oatp1, Oatp2, and Oatp4. In human liver, Na + -independent bile salt uptake is predominantly mediated by OATP-C (LST-1/OATP2) and OATP8. OATP-B is expressed predominantly in the liver but does not transport bile salts (unpublished observations). At the canalicular membrane, excretion of monovalent bile salts is mediated by the bile salt export pumps Bsep (rat)/BSEP (human), which are members of the multidrug resistance (Mdr) gene product family. Excretion of non-bile salt organic anions such as bilirubin glucuronides, as well as of divalent sulfated or glucuronidated bile salts, is mediated by the multidrug resistance protein 2, Mrp2 (rat)/MRP2 (human). Mrp1 (MRP1) and Mrp3 (MRP3) are normally expressed at low levels in hepatocytes but are increased during cholestasis to compensate for reduced Mrp2 (MRP2) expression and to maintain ongoing organic anion efflux from the hepatocyte. Within the bile ducts of rats, conjugated bile salts can be absorbed by the ileal bile salt transporter (Ibat) that is localized on the apical cholangiocyte membrane. After uptake by cholangiocytes, bile salts are translocated into the sinusoidal circulation by a basolateral anion exchanger that has been postulated to be identical with rat Oatp3. Whether similar "cholehepatic shunting"
of bile salts occurs also in human liver remains to be investigated. (Table 1 ). This conclusion is further supported by antisense studies in Xenopus laevis oocytes, which showed that selective inhibition of Ntcp expression in oocytes injected with total rat liver mRNA resulted in a 95% reduction of Na + -dependent taurocholate uptake. 31 The only non-bile salt substrate that is transported to any noteworthy degree by Ntcp is estrone-3-sulfate. 32 Ntcp expression is subject to extensive regulation in various physiologic and pathophysiologic settings associated with altered sinusoidal uptake of bile salts. Both mRNA and protein levels are downregulated in rat models of cholestasis such as bile duct ligation, 33,34 endotoxinemia, 35, 36 and ethinyl estradiol induced cholestasis. 37 In bile fistula rats, which have decreased concentrations of biliary constituents, mRNA and protein levels are unchanged. 38, 39 In contrast, experimental increases in the transhepatic flux of bile salts were found to transiently decrease Ntcp expression in a choledochocaval fistula model 38 but not in a streptozotocindiabetes model. 39 Overall, physiologic fluctuations in transhepatic bile salt flux are unlikely to exert any significant effect on Ntcp expression. The upregulation of hepatic bile salt uptake that occurs in postpartum rats and in rats treated with prolactin 40 is attributable to the stimulation of Ntcp gene expression secondary to increased nuclear translocation of phosphorylated Stat5, a transcription factor that binds to the Ntcp gene promoter. 41 A detailed review of the transcriptional regulation of hepatic transporter genes is presented elsewhere in this issue.
Ntcp function is regulated not only by changes in gene expression and consequently protein synthesis but also by protein trafficking and the rate of insertion of Ntcp into the plasma membrane. In HepG2 cells transfected with a carboxy-terminal-tagged green fluorescent protein conjugate of Ntcp, addition of 100 mol/l dbcyclic AMP (cAMP) stimulated Ntcp-associated membrane fluorescence by 40% within 2.5 minutes and cellular taurocholate uptake by 30%. 42 This explains the previously observed stimulation of sodium-dependent taurocholate uptake in hepatocytes pretreated with cAMP. 43,44 cAMP causes rapid translocation of Ntcp from a preformed vesicular pool to the plasma membrane via the actin cytoskeleton. 42 . This represents an important mechanism for short-term regulation of basolateral bile salt uptake velocity in response to physiologic stimuli. cAMP also stimulates apical membrane targeting and bile salt secretion in rat hepatocytes. The microfilament inhibitor cytochalasin D inhibits the cAMP effect on basolateral Ntcp insertion but not on the canalicular excretion of bile salts or organic anions. 45 Whereas the cAMP effect on Ntcp is a microfilamentdependent process, canalicular transporter insertion is microtubule dependent because it is inhibitable by nocodazole. 46 In contrast to cAMP, exposure of Ntcp green fluorescent protein expressing HepG2 cells to 10mol/l taurocholate has no effect on Ntcp membrane insertion. 30 In mice, two alternatively spliced Ntcp isoforms (Ntcp1, Slc10a1; Ntcp2, Slc10a2) have been isolated, both of which mediate saturable Na + -dependent taurocholate transport when expressed in oocytes (K m for Ntcp1 ϳ 86 M, K m for Ntcp2 ϳ 14 M). Ntcp1 is a 362 amino acid protein and is the predominant form expressed in mouse liver, whereas Ntcp2 is a truncated 317 amino acid protein that is produced by alternative splicing. 24 Human NTCP (SLC10A1) is a 349 amino acid protein with a higher affinity for taurocholate (K m ϳ 6 M) than the rat and mouse orthologues 23 . The NTCP gene maps to chromosome 14.
A second protein that has been proposed to be involved in sodium-dependent bile salt uptake across the basolateral hepatocyte membrane is the enzyme microsomal epoxide hydrolase (mEH), 47 a bifunctional protein that is localized on both the smooth endoplasmic reticulum (SER) and the hepatocyte sinusoidal plasma membrane. 48, 49 The microsomal isoform of mEH has been shown to mediate Na + -independent, electrogenic, 4,4Ј-diisothiocyanostilbene-2,2Ј-disulfonic acid (DIDS) inhibitable bile salt uptake into hepatocyte SER vesicles. 50 The mEH epitope found on the surface of hepatocytes is also found on the cytoplasmic surface and in the lumen of right-side-out oriented SER vesicles. Thus, two forms of mEH are present in the SER, the luminal form being sorted to the cell surface. The purpose of bile salt binding to the SER could be intracellular vesicular transport from the basolateral to the canalicular domain. 50 To directly establish a role for the cell surface form of mEH (Ephx1) in sinusoidal bile salt uptake, von Dippe et al. 48 transfected Madin-Darby canine kidney cells with the mEH cDNA and showed Na + -dependent DIDS inhibitable transport of taurocholate. This is at variance with the lack of taurocholate transport in mEH transfected baby hamster kidney cells. 51 Interestingly, mEH expressing Madin-Darby Canine Kidney cells also exhibited Na + -dependent transport of cholate at levels of 150% of taurocholate transport, whereas in hepatocytes Na + -dependent cholate uptake amounts only to about 30% of taurocholate uptake. Furthermore, mEH mediated taurocholate uptake was inhibited by 37 M bovine serum albumin, 48 whereas albumin exerts a stimulatory effect on Na + -dependent taurocholate uptake in the isolated perfused rat liver at a concentration of 75 Also, among all physiologic bile salts, taurochenodeoxycholate exerts the strongest inhibitory effects on hepatocellular and Ntcp-mediated taurocholate transport, 10 whereas mEH-mediated taurocholate transport is more sensitive to cholate. 48 Although these data have been interpreted to indicate that mEH may participate in Na + -dependent cholate uptake, it is important to consider that more than 50% of hepatocellular cholate uptake is Na + independent 18,56,57 and that Ntcp is also capable of mediating cholate transport. 58 Finally, the observation that mEH knockout mice have no phenotypic abnormalities further indicate that mEH is not critical for physiologic bile salt homeostasis. 59 Hence, the exact role of mEH in overall hepatocellular bile salt uptake still needs to be elucidated.
Na + -independent Bile Salt Uptake Systems
Whereas the features of Na + -dependent hepatocellular bile salt uptake can largely be reconciled with the functional characteristics of Ntcp and NTCP in both rodent and human hepatocytes, respectively, the Na + -independent uptake of bile salts cannot be attributed to the function of a single transport system. Based on vesicle studies, several carrier systems have been proposed. These include a sulphate/anion exchanger, 60 a dicarboxylate/anion exchanger 13,61 and arguably an OH Ϫ / cholate anion exchanger 15, 62, 63 . An important feature of the Na + -independent bile salt uptake pathway is its wide transport substrate preference, which includes conjugated and unconjugated bile salts 18,56 , bromosulphophthalein (BSP), DIDS, 56,64-67 cardiac glycosides and other neutral steroids, 68-70 linear and cyclic peptides, 18,56,71 selected organic cations, 69, 70 and numerous drugs such as pravastatin. 72 In view of this broad substrate preference of the involved transport system(s), the term "multispecific bile acid transporter" was coined. 18, 56 Many "classic" biochemical approaches aimed at isolating a Na + -independent hepatocellular organic anion uptake system on the basis of binding properties for the organic anion BSP. A BSP/bilirubin binding protein was isolated from rat liver by affinity chromatography over BSP-agarose, 73, 74 but a functional cDNA has not been identified to date. The organic anion binding protein (OABP) was identified by photoaffinity labeling and subsequently purified by affinity chromatography. 75, 76 An OABP-cDNA clone was isolated by immunoscreening of a rat liver cDNA library and shown to be closely related to the ␤ subunit of mitochondrial F 1 -ATPase. 77 Finally, bilitranslocase (BTL) has been proposed as a sinusoidal bilirubin uptake system. 78 BTL is detectable in rat liver, gastric mucosa, and central nervous system by immunoblot analysis, 79 but the characterization of the BTL-cDNA is still underway. *Because Na + -independent bile salt transporters are also active in the presence of Na + , most K m values in liver, hepatocytes, and membrane vesicles determined in the presence of Na + include both Na + -dependent and Na + -independent uptake processes. In contrast, K m values for Ntcp/NTCP and Oatps/OATPs refer strickly to Na + -dependent and Na + -independent uptake activities, respectively. †Symbols in parenthesis refer to the official classification of the human (www.gene.ucl.ac.uk/nomenclature), rat, and mouse (www.informatics.jax.org) genome nomenclature committee.
Because of the potential pitfalls of the classic approaches-described in detail in an excellent review by Berk et al. 80 -an expression cloning approach was used that yielded the first functional transporter cDNA to confer uptake of BSP in heterologous expression systems. 81 This organic anion transporting polypeptide 1 (Oatp1; Slc21a1) of rat liver mediated Na + -independent uptake of BSP (K m ϳ 1.5-3 µM) and taurocholate (K m ϳ 19-50 µM) when expressed in X. laevis oocytes. [81] [82] [83] [84] In addition to taurocholate, Oatp1 also transports other bile salt derivatives (Table 1) 
, and taurohyodeoxycholate (K m ϳ 7.5 M). 85 Oatp1 is a 670 amino acid protein with an apparent molecular mass of 80 kDa that is localized in the basolateral membrane of hepatocytes ( Fig. 1) 84, 86, 87 and at the apical membranes of kidney proximal tubular cells 86 and of choroid plexus epithelial cells. 88, 89 Many functional characteristics of Oatp1 indicate that it could represent the multispecific bile acid transporter identified in previous experimental models. 18, 56 Thus, studies in numerous heterologous expression systems have shown that besides BSP and bile salts, the spectrum of Oatp1 substrates also includes estrone-3-sulfate (K m ϳ 5-11 µM), 84, 90 dehydroepiandrosterone sulfate (DHEAS) (K m ϳ 5 µM), 84 101 and even the organic cations N-(4,4-azo-n-pentyl)-21deoxyajmalinium or APD-ajmalinium 90, 102 and to a lesser degree also Nmethyl-quinine and rocuronium. 102 However, and most importantly, despite its wide substrate preference, Oatp1 does not transport unconjugated bilirubin. 93 The Oatp1 of mouse liver has also been isolated and shown to have the same substrate specificity as rat Oatp1. 103 Kinetic analyses of mOatp1 mediated transport show apparent K m values of 12 µM for taurocholate and 5 µM for estrone-3-sulphate. The mOatp1 gene maps to chromosome XA3-A5 and is expressed predominantly in the liver, with additional expression in the kidney. 103 The driving force for Oatp1-mediated organic anion uptake appears to be anion exchange, as evidenced by bidirectional transmembrane BSP transport in Oatp1 expressing HeLa cells 104 and by Oatp1 mediated taurocholate/HCO 3 exchange. 83 A recent study by Li et al. 92 showed increased [ 3 H]GSH (glutathione) efflux from oocytes expressing Oatp1 92 and a stoichiometry of GSH/taurocholate exchange of 1:1. 92 Thus, Oatp1 participates in overall GSH efflux from hepatocytes, and this physiologic GSH efflux could represent an important driving force for Oatp1 mediated substrate uptake into hepatocytes. Finally, Oatp1 has recently been shown to be serine phosphorylated by the addition of extracellular ATP and/or phosphatase inhibitors, which decreases transport activity by up to 85%. 105 Antisense studies in oocytes showed that selective inhibition of Oatp1 in oocytes injected with total rat liver mRNA reduced Na + -independent uptake of taurocholate and BSP by 80% and 50%, respectively, indicating that additional Na + -independent organic anion uptake systems must be present in rat liver. 31 Based on homology with Oatp1, a second Oatp-Oatp2 (Slc21a5)-was cloned from rat brain and shown to be also expressed in rat liver. 106 Oatp2 exhibits a 77% amino acid identity with Oatp1. Its spectrum of transport substrates is similar (Table 1) , but not identical, to Oatp1 and includes taurocholate (K m ϳ 35 µM), 106 cholate (K m ϳ 46 µM), 106 glycocholate (K m ϳ 40 M), 87 taurochenodeoxycholate (K m ϳ 12 µM), 87 tauroursodeoxycholate (K m ϳ 17 µM), 87 DHEAS (K m ϳ 17 µM), 87 estradiol-17␤-D-glucuronide (K m ϳ 3 µM), 106 T 3 (K m ϳ 5.9 µM) and T 4 (K m ϳ 6.5 µM), 107 ouabain (K m ϳ 470 M), 106 digoxin (K m ϳ 0.24 µM), 106 pravastatin (K m ϳ 38 M), 108 the endothelin antagonist BQ-123 (K m ϳ 30 µM), 87 the opioid receptor agonists DPDPE (K m ϳ 19 M) 100 and Leu-enkephalin, 109 biotin, 109 fexofenadine (K m ϳ 6.0 M), 101 and the bulky type II organic cations APD-ajmalinium and rocuronium. 102 In comparison with Oatp1, substrates such as bilirubin monoglucuronide, BSP, leukotriene C 4 , and Gd-EOB-DTPA are not transported by Oatp2. 87 Oatp2 is a 661 amino acid protein with a native apparent molecular mass of 92 kDa in the basolateral plasma membrane of hepatocytes. 87 Oatp2 is expressed not only in hepatocytes, but also in the retina, 107 in endothelial cells of the blood-brain barrier, 89 and at the basolateral plasma membrane of choroid plexus epithelial cells. 89 An important difference between Oatp1 and Oatp2 was observed with respect to their acinar localization in the liver. Whereas in situ hybridization and immunofluorescence studies showed a homogeneous distribution of Oatp1 within the liver acinus, 87, 110 Oatp2 exhibits a heterogeneous lobular distribution with pre-279 HEPATIC TRANSPORT OF BILE SALTS-KULLAK-UBLICK ET AL. dominant expression in perivenous hepatocytes excluding the innermost one to two cell layers surrounding the central vein. 87, 109 Interestingly, treatment of rats with phenobarbital at a dose of 80 mg/kg/d over 5 days resulted in a significant increase in Oatp2 expression and in the appearance of positive immunofluorescence signals even in the innermost layer of perivenous hepatocytes. 111 Thus, the increase in the plasma disappearance rates of ouabain, digoxin, and thyroxine that have been observed secondary to phenobarbital treatment [112] [113] [114] [115] [116] could be attributed to the increase in hepatic Oatp2 expression. However, the hepatic uptake of bile salts, which occurs predominantly in periportal hepatocytes, 6 is unaffected by phenobarbital treatment, 117 which is consistent with normal expression of Ntcp, Oatp1, and Oatp4 (see below) in phenobarbital-treated rats. 111 The driving force of Oatp2-mediated solute transport has not been studied in detail, but initial experiments indicate that Oatp2 may exhibit asymmetric transport properties with GSH and GSH conjugates being accepted as intrabut not extracellular substrates and their outwardly directed transport being coupled with bile salt and organic anion uptake into hepatocytes. 118 A third Oatp that can mediate Na + -independent uptake of bile salts in rat hepatocytes is Oatp4 (Slc21a10), a full-length isoform of the so-called liver-specific transporter 1 or rlst-1 (Table 1) . 119, 120 In comparison to rlst-1, Oatp4 is more strongly expressed in rat liver, contains an additional 35 amino acids, and exhibits a predicted 12 transmembrane topology that is characteristic of all other Oatps. 120 Furthermore, although the transport activity of rlst-1 is restricted to taurocholate (K m ϳ 9 M), Oatp4 accepts numerous organic anions as transport substrates including taurocholate (K m ϳ 26.5 M), BSP (K m ϳ 1.1 M), estrone-3-sulfate, estradiol-17␤-glucuronide, DHEAS, prostaglandin E 2 , leukotriene C 4 , the thyroid hormones T 3 and T 4 , and gadoxetate. 120 Oatp4 shares 43% and 44% amino acid identities with Oatp1 and Oatp2, respectively. Collectively, a comparison of the data on Oatp mediated bile salt transport with the data on Na + -independent bile salt uptake obtained in previous experimental systems indicates that the Oatp transporters cloned to date can account for the bulk of Na + -independent bile salt uptake in rat liver (Table 1) . Parenthetically, additional rat Oatps not expressed in hepatocytes and/or not involved in bile salt transport include the prostaglandin transporter (rPGT) (Slc21a2), 121 OAT-K1/2 (Slc21a4), 122, 123 and Oatp3 (Slc21a7). 107 In human liver, only few functional data are available on the Na + -independent uptake of bile salts. The predominant uptake system identified to date is the liver-specific transporter 1 (LST-1), 124 which has also been called OATP2, 99, 125 although it does not represent the orthologue of the rat Oatp2. Furthermore, the same protein has been deposited in the GeneBank as "OATP-C" (accession number, AB026257). To keep the functionally based designation "OATP" and to avoid false associations of nonorthologous gene products between species, the human LST-1/OATP2/OATP-C (gene symbol SLC21A6) will henceforth be called OATP-C. OATP-C is selectively expressed at the basolateral membrane of hepatocytes, 125 consists of 691 amino acids, and exhibits the highest (64%) amino acid identity with the Oatp4 of rat liver (Fig. 2) . Accordingly, the substrate specificities of OATP-C and Oatp4 are very comparable, although it remains uncertain whether the two proteins represent truly orthologous gene products ( Table 1) . Transport substrates of OATP-C include taurocholate (K m ϳ 14-34 M), 99, 124 bilirubin monoglucuronide, DHEAS, estradiol-17␤-glucuronide (K m ϳ 8 M), 125 estrone-3-sulphate, prostaglandin E 2 , thromboxane B 2 , leukotriene C 4 , leukotriene E 4 , T 3 (K m ϳ 3 M), T 4 (K m ϳ 3 M), 124 pravastatin (K m ϳ 35 M) 99 , and BSP (K m ϳ 0.3 M) (G.A. Kullak-Ublick and P.J. Meier, unpublished data, 2000) . Although the bile salt and organic anion transport properties of OATP-C remain to be investigated in more details, the studies available so far indicate that OATP-C represents an important if not the predominant Na + -independent bile salt uptake system of human liver.
A second human Na + -independent bile salt uptake system is OATP-A (previously called OATP; SLC21A3). 126 Although OATP-A was originally isolated from human liver, it is predominantly expressed in human cerebral endothelial cells. 100 127 DHEAS (K m ϳ 6.6 µM), 128 the magnetic resonance imaging agent Gd-B 20790, 129 the opioid receptor agonists DPDPE (K m ϳ 202 M) and deltorphin II (K m ϳ 330 M), 100 the antihistamine fexofenadine, 101 and the amphipathic organic cations APD-ajmalinium, rocuronium, N-methyl-quinine (K m ϳ 5 µM) and Nmethyl-quinidine (K m ϳ 26 µM). 102 Thus, in contrast to the preference of OATP-C for organic anions, the spectrum of OATP-A substrates also includes amphipathic organic cations, indicating that it can mediate charge independent solute movement across membranes. OATP-A is a 670 amino acid protein with an apparent molecular mass of ϳ 85 kDa in human liver. 130 The levels of amino acid identity are 67% with rat Oatp1, 73% with rat Oatp2, 42% with rat Oatp4, and 44% with human OATP-C. Finally, several additional human OATPs have been identified, including the human prostaglandin transporter hPGT (SLC21A2), 131 
OATP-B (SLC21A9), OATP-D (SLC21A11), and OATP-E (SLC21A12).
Whether these latter and/or additional as yet unidentified human OATPs are also involved in hepatocellular Na + -independent bile salt uptake remains to be investigated. As illustrated in Figure 2 , the phylogenetic relationships between the various organic anion transporting polypeptides indicate that the Oatps/OATPs may actually form a gene superfamily with closely and more distantly related family and subfamily members that exhibit partly redundant and partly distinct amphipathic organic solute transport properties in various organs.
Basolateral Bile Salt Efflux
A prerequisite for the maintenance of bile formation is the continuous hepatocellular extraction of bile salts from portal blood and their excretion into bile. Under normal conditions, the physiologic substrate and ion gradients ensure ongoing Ntcp/NTCP-and Oatp/OATP-mediated basolateral bile salt uptake. However, under pathophysiologic conditions such as cholestasis, this transport polarity may be disrupted by alterations in canalicular and basolateral transporter expression as detailed elsewhere in this issue and in several recent review articles. [132] [133] [134] [135] [136] A major consequence of extrahepatic bile duct obstruction is the transient downregulation of the canalicular transport systems for monovalent and divalent bile salts. 137, 138 In contrast, the lateral multidrug resistance associated protein 1 (Mrp1) and the basolateral Mrp3, normally expressed at very low levels in hepatocytes, are upregulated in cholestasis. 9, [139] [140] [141] This upregulation compensates for reduced canalicular organic anion efflux by increasing the sinusoidal efflux of divalent bile salt conjugates via Mrp1 and Mrp3. 142 However, the dianionic bile salt sulfolithotaurocholate is also a substrate of Oatp1, 87 suggesting that dianionic bile salts may also be effluxed via this transport pathway. Divalent bile salt conjugates and bilirubin glucuronides that are effluxed across the sinusoidal membrane into the systemic circulation are subsequently eliminated into urine by various transport pathways in renal tubular cells. Evidence for this route of elimination was obtained in early studies that reported increased urinary levels of sulfated and glucuronic acid conjugated bile salts in patients with cholestatic liver disease. 143, 144 It seems likely that a certain proportion of bile salts that accumulate intracellularly during cholestasis and that are effluxed across the sinusoidal membrane is not dianionic but remains in the monovalent form. The route by which these bile salts are transported back into the sinusoidal blood is likely to involve the Oatps/ OATPs, because these function bidirectionally as described above. Whereas Oatp1 and rlst-1 are downregulated in experimental models of cholestasis such as bile duct ligation 34,119 and endotoxinemia, 119, 145 Oatp2 expression is preserved during cholestasis. In human liver, similarly to rat Oatp2, OATP-A expression is also preserved or even moderately increased in patients with the cholestatic liver disease primary sclerosing cholangitis. 146 In addition to Oatp/OATP mediated monovalent bile salt efflux, Mrp3 has recently been shown to be capable of mediating sinusoidal bile salt efflux (Table 1) . 147 The exact contribution of each Oatp/OATP and Mrp/MRP in mediating the sinusoidal efflux of monoanionic bile salts and dianionic bile salt conjugates may depend on the type of pathophysiologic condition and concurrent medication and remains to be elucidated in the established rat models of cholestasis and in human cholestatic liver disease.
INTRACELLULAR BILE SALT TRANSPORT
The intracellular transport of bile salts is less well understood than the events that occur at the basolateral and canalicular plasma membrane. Most bile salts that are excreted across the canalicular membrane are taken up from sinusoidal blood, whereas less than 5% originate from hepatic de novo synthesis. Transcellular bile salt passage can occur within seconds, and an intravenous bolus is almost totally recovered in bile within 10 minutes. 148 Several mechanisms have been proposed to play a role in transcellular bile salt trafficking. Bile salts bind intracellularly to binding proteins, which reduces their potential toxicity. 149 They have also been found to associate with intracellular membranes, suggesting a vesicular component in hepatocyte transport. 150 The possible significance of these pathways will be outlined in the light of current experimental evidence.
After uptake across the basolateral membrane, bile salts bind to cytosolic binding proteins, in particular the YЈclass proteins 3␣-hydroxysteroid dehydrogenase in rat liver and hepatic bile acid-binding protein (HBAB) in human liver. [151] [152] [153] [154] In rat liver, the glutathione-Stransferases and hepatic fatty acid binding protein (H-FABP) also bind bile salts, 149, 155, 156 whereas in human liver both proteins have significantly higher dissociation constants for bile salts than the 36-kDa H-FABP. 157 Photoaffinity labeling studies in rat liver showed differential binding properties for sulfated as compared with nonsulfated taurine-conjugated bile salts, the former binding exclusively to H-FABP and the latter to several cytosolic proteins. 156 Human HBAB is a dihydrodiol dehydrogenase, similar to 3␣-hydroxysteroid dehydrogenase of rat liver, that belongs to the monomeric oxidoreductase gene family but lacks 3␣-hydroxysteroid dehydrogenase activity for bile salts. 152 It consists of 323 amino acids and is encoded by a 1.25-kb cDNA that was originally cloned from HepG2 cells. 154 Binding affinities for lithocholate and chenodeoxycholate are 1.1 and 3.34 µM, respectively. 154 Several lines of evidence suggest that delivery of protein-bound bile salts to the canalicular membrane occurs primarily via diffusion. 158 Morphometric studies using electron microscopic and immunofluorescence techniques showed strong association of bile salts with intracellular organelles during transport across the hepatocytes, a phenomenon that was interpreted as reflecting vesicular transcytosis. The endoplasmic reticulum (ER) but not the Golgi apparatus was shown to possess an electrogenic bile salt transport system of unclear physiologic significance. 50, 159 Using polyclonal antibodies against cholic acid conjugates, 160 positive immunoreactivity was observed by electron microscopy on vesicles of the Golgi apparatus and the SER. 149 Fluorinated bile salt analogues localized to membranes of the ER and Golgi, 150 and fluorescein isothiocyanateglycocholate (FITC-GC) was shown to colocalize with the Golgi marker C 6 -NBD-ceramide. 161 The inhibition of FITC-GC transport from the Golgi to the canaliculus by colchicine indicated microtubule-dependent vesicular movement. 161 However, electron spectroscopic analysis of isolated rat hepatocytes exposed to 50 µM of the 2-fluoro␤-alanine N-acyl amidate conjugate of cholic acid detected fluorine in the membranes but not the lumen of the ER and Golgi apparatus. 150 The lack of luminal sequestration of bile salts cast doubt on the proposed role for vesicular transport within hepatocytes.
To directly analyze the role of vesicular transport of bile salts, Wilton et al. 162 incubated hepatocyte couplets with fluorescent derivatives of cholate, chenodeoxycholate, lithocholate, and ursodeoxycholate and used colchicine and brefeldin A to inhibit vesicular transport. Whereas the delivery of ursodeoxycholate and lithocholate to the canaliculus was reduced to 25% of control levels by colchicine and to Յ23% by brefeldin A, no effect was seen on the canalicular accumulation of cholate and chenodeoxycholate. Thus, transport of lithocholate and ursodeoxycholate, but not cholate and chenodeoxycholate, was dependent on vesicle-mediated transcytosis. Similar results were obtained by El-Seaidy et al. 163 who exposed rat hepatocyte couplets to fluorescent derivatives of cholate and chenodeoxycholate. In agreement with Wilton et al., colchicine had no effect on canalicular fluorescence, providing further evidence against intracellular sequestering or microtubuledependent trafficking of bile salts before canalicular secretion. Whereas this conclusion may apply to bile salt excretion under basal conditions, the excretion of high bile salt loads in the perfused rat liver has been shown to be delayed by colchicine treatment, 148 indicating a role for vesicle-mediated transport at high bile salt concentrations (for instance, in the postabsorptive state). The trans-Golgi complex does not participate in vesicular transport even under high bile salt loads, because coinfusion of the Na + -ionophore and Golgi inhibitor monensin during bolus injections of taurocholate did not alter biliary taurocholate secretion in the perfused liver. 164 Despite the fact that under basal conditions biliary bile salt secretion does not directly involve microtubule-dependent vesicular transport, the increasing dependence on such a mechanism at high bile salt loads and the interaction of bile salts with organelle membranes already at low bile salt concentrations remain unresolved. Bile salts have been shown to modulate intracellular lipid movement 165, 166 and microtubule function, 163,167 the latter being critical for the regulated insertion and retrieval of transport proteins into and from the canalicular membrane. 158, 168, 169 Vesicular recycling of canalicular transporters between the plasma membrane and the trans-Golgi is microtubule dependent and subject to regulation by bile salts, explaining the correlation between pericanalicular vesicle fusion with the canalicular membrane and increased taurocholate transport maximum during bile salt infusion in the perfused liver. 170 The degree of regulation by bile salts depends in part on their hydrophobicity, a determinant for activation of second messenger pathways such as cytosolic free calcium [Ca ++ ] i and protein kinase C. 135, 158 
CANALICULAR SECRETION OF BILE SALTS
Canalicular secretion represents the rate-limiting step in the overall secretion of bile salts from blood into bile. Whereas bile salt concentrations within the hepatocyte are in the micromolar range, canalicular bile salt concentrations are more than 1,000-fold higher, necessitating active transport across the canalicular hepatocyte membrane. Studies in canalicular hepatocyte membrane vesicles identified both electrogenic and ATP-282 dependent bile salt transport mechanisms. 171 Using electrophoretic subcellular fractionation techniques, electrogenic transport was subsequently localized to a subcanalicular microsomal compartment 159, 172 and the involved transport system could represent the smooth endoplasmic reticulum isoform of mEH. 50 Characterization of ATP-dependent taurocholate transport in canalicular membrane vesicles indicated the presence of a specific carrier system that was preferentially inhibited by conjugated monovalent bile salts but not by substrates of the ATP-dependent transport systems for organic cations or non-bile salt organic anions such as daunomycin, GSH, and glutathione conjugates. 173, 174 These vesicle studies confirmed the established notion that the bile salt export system is distinct from the multispecific organic anion transporter that mediates the canalicular efflux of glucuronic acid and GSH conjugates. The role of the canalicular multispecific organic anion transporter in the transport of sulfated bile salts was confirmed in a recent study analyzing the biliary excretion of sulfated and nonsulfated fluorescent bile salts in TRrats, which have a selective canalicular transport defect for non-bile salt organic anions. 175 In TR Ϫ rats, biliary excretion of sulfated fluorescent lithocholate was reduced to 6% compared with normal rats, whereas excretion of non-sulfated fluorescent glycocholate and lithocholate was reduced to 66% and 52%, respectively.
Kinetic studies in canalicular membrane vesicles revealed a K m for ATP-dependent taurocholate transport of ϳ 2-20 µM. 173, 174, 176, 177 Attempts to purify the protein by photoaffinity labeling or affinity chromatography strategies resulted in the isolation of a 110-kDa bile salt binding protein that was identical with the canalicular ectoATPase. 176, 178 Although ectoATPase was proposed as a candidate bile salt transporter, 177,178 studies using a bile salt-resistant hepatoma cell line showed that the involved protein belongs to the ATP-binding cassette (ABC) type of membrane transporter. 179 Furthermore, the presence of an ATP-dependent taurocholate transporter other than ecto-ATPase was shown in rat hepatoma HTC cells. 180 In yeast, an ABC-type protein called BAT1 was shown to represent an ATP-dependent bile salt transporter. 181 
Molecular and Functional Characteristics of Bile Salt Export Pump (Bsep)
Based on the sequence of a novel gene closely related to the P-glycoproteins expressed in pig liver, 182 a full-length homologue of this "sister gene to P-glycoprotein" (Spgp) was cloned from rat liver. 183 In membrane vesicles from transfected Sf9 cells, the rat Spgp conferred a fivefold stimulation of ATP-dependent taurocholate transport as compared with control vesicles, indicating that it represents a bile salt transporting ABC-type protein. The K m for taurocholate transport was ϳ5 µM, and the relative transport rates for various bile salts were comparable with ATP-dependent transport in canalicular rat liver plasma membrane vesicles. 183 These functional data, coupled with the hepatocyte-specific expression of Spgp on the surface of canalicular microvilli, indicated that Spgp represents a genuine bile salt export pump (Bsep) of mammalian liver. In addition to taurocholate, Bsep also mediates ATP-dependent transport of glycocholate, taurochenodeoxycholate (K m ϳ 2 M), and tauroursodeoxycholate (K m ϳ 4 M) ( Table 1 ). The identification of the human BSEP gene locus as the positional candidate for progressive familial intrahepatic cholestasis type 2 (PFIC2), a progressive liver disease characterized by low biliary bile salt concentrations, was highly indicative of the role of BSEP as the major canalicular bile salt export pump. 184 In PFIC2, BSEP is absent from the canalicular membrane and biliary bile salt concentrations are less than 1% of normal. 185 Several mutations in the BSEP gene have been identified in these patients. 185 The rat Bsep is a 1,321 amino acid protein with 12 putative membrane-spanning domains, four potential Nlinked glycosylation sites, a molecular mass of ϳ160 kDa, and with the structural features of the ABCtransporter superfamily. 183 The amino acid sequence is 49% and 48% identical with rat Mdr1b and Mdr2, respectively, and 26% and 25% identical with human MRP1 and rat Mrp2, respectively, indicating a closer homology with the Mdr than with the Mrp gene family. In skate liver, a 210-kDa protein is recognized by an antibody againts rat Bsep. 186 It is unknown whether ATPdependent taurocholate transport in skate liver plasma membrane vesicles (K m ϳ 40 µM) is mediated by this putative Bsep homologue. 186 The murine homologue mBsep is 90% and 81% identical with rat Bsep and human BSEP, respectively, and represents a 160-kDa canalicular membrane protein. 187, 188 The K m for taurocholate transport in membranes isolated from mBseptransfected Balb-3T3 cells was 11 µM. 188 The mBsep gene was localized to mouse chromosome 2, band 2C1.3, 187 a region homologous with the locus of human BSEP on chromosome 2q24. 184 Interestingly, this region has been linked not only to PFIC2 in humans, but also to genetic gallstone susceptibility in the C57L mouse strain. 189, 190 These mice overexpress Bsep 191 and exhibit relative hypersecretion of cholesterol into bile with subsequent cholesterol supersaturation. 192 Presumably, overexpression of Bsep in these mice results in hypersecretion of bile salts that in turn promotes the hypersecretion of cholesterol due to molecular coupling of bile salt and cholesterol secretion. 193 Excess biliary bile salts could lead to increased bile salt absorption within the biliary tree via the Na + -dependent ileal bile acid transporter (IBAT) expressed at the apical surface of cholangiocytes, 194 leaving bile supersaturated with cholesterol.
HEPATIC TRANSPORT OF BILE SALTS-KULLAK-UBLICK ET AL.
In view of experimental data showing that IBAT is upregulated by increased luminal taurocholate concentrations, 195 increased ductular bile salts could upregulate cholangiocellular IBAT and thereby increase their own rate of absorption. However, the exact role of Bsep in biliary lipid secretion remains to be elucidated.
Regulation of Bsep in Cholestasis
Because ATP-dependent bile salt efflux into the canaliculus is the major driving force and the ratelimiting step in bile formation, this transport pathway is a vulnerable target for the inhibition of bile flow and the development of intrahepatic cholestasis. In experimental sepsis secondary to lipopolysaccharide (LPS) administration, ATP-dependent uptake of 5 µM taurocholate in canalicular plasma membrane vesicles was reduced to 53% of controls without an apparent change in K m , suggesting a decrease in the number of Bsep molecules in the canalicular membrane. 196 A reduction of Bsep protein levels to 52% of controls after LPS administration was confirmed by Western blot analyses. 138 The expression of the canalicular organic anion transporter Mrp2 was decreased even more profoundly, amounting to 11% of controls in the LPS model. 138 LPS was shown to induce an early and selective but reversible retrieval of Mrp2 from the canalicular membrane, 197 whereas phalloidin induced an unselective and irreversible loss of Mrp2 and other proteins from the canalicular membrane. 198 In ethinyl estradiolinduced cholestasis, ATP-dependent canalicular taurocholate transport is also reduced, with kinetic parameters that suggest a reduction in the number of ATPdependent bile salt carriers at the canalicular membrane. 199 Accordingly, Bsep protein levels amounted to 53% and Mrp2 protein levels to 20% of controls after ethinyl estradiol treatment. 138 During extrahepatic bile duct obstruction caused by bile duct ligation, Bsep protein levels were decreased to 49% and Mrp2 protein levels to 12% of controls after 3 days. 137, 138 Whereas Bsep secretes monovalent bile salts such as taurocholate, Mrp2 mediates the ATP-dependent export of divalent organic anions such as bilirubin glucuronides and sulfated or glucuronidated bile salt conjugates. 200, 201 Sulfation of toxic monovalent bile salts such as taurolithocholate is a means by which the hepatocyte converts these bile salts into divalent organic anions that do not reenter the enterohepatic circulation after their excretion into the intestine. Sulfation or glucuronidation of bile salts renders them substrates of the Mrp class of organic anion transporters, facilitating their efflux into the sinusoidal space via Mrp1, Mrp3, and Oatps in situations in which the canalicular efflux systems are impaired. Whereas Mrp2 is strongly downregulated in many models of cholestasis, the relative preservation of Bsep expression serves to maintain the canalicular efflux of bile salts even during bile duct ligation, as has been demonstrated experimentally. 202 
Inhibition of Bsep in Drug-induced Cholestasis
Whereas the above-mentioned models of cholestasis are associated with decreased expression levels of Bsep and Mrp2, canalicular transport may also be reduced by direct steric inhibition of individual efflux pumps (Fig. 3) . Thus, the mechanism of cyclosporin Ainduced cholestasis appears to be a direct inhibition of canalicular bile salt transport. 203 In membrane vesicles isolated from Bsep expressing Sf9 insect cells, ATPdependent taurocholate transport is inhibited with a K i value of 0.3 µM. 204 This is comparable with the K i value obtained in rat liver canalicular plasma membrane vesicles. 203 Inhibition of canalicular bile salt transport via Bsep was also found for the cholestatic drugs rifamycin and rifampicin, 204 and inhibition of Bsep-mediated calcein-acetoxymethyl ester efflux from mBsep expressing pig kidney LLC-PK1 cells was shown for the linear hexapeptide ditekiren. 187 In addition to cis-inhibition by the above named compounds, trans-inhibition of Bsep has been shown for the cholestatic estrogen metabolite estradiol-17␤-glucuronide, an Mrp2 substrate. 204 Estradiol-17␤-glucuronide inhibited ATP-dependent taurocholate uptake in canalicular liver plasma membrane vesicles from normal rats but not Mrp2-deficient GY/TR -rats. 204 Accordingly, estradiol-17␤-glucuronide induced inhibition of taurocholate uptake in Sf9 cell vesicles was found only in Bsep/Mrp2 double transfectants, but not in vesicles expressing only Bsep. 204 These data strongly suggest that estradiol-17␤-glucuronide first needs to be effluxed into the canalicular lumen by Mrp2 before being able to exert an inhibitory effect on Bsep function.
Finally, Bsep has been identified as a target of inhibition by abnormal bile salt metabolites formed in 3␤-hydroxy-⌬ 5 -C 27 -steroid dehydrogenase/isomerase deficiency. 3␤,7␣-Dihydroxy-5-cholenoic acid and 7␣-hydroxy-3-oxo-4-cholenoic acid both inhibit ATPdependent taurocholate transport in canalicular liver plasma membrane vesicles with K i values of 15 and 16 µM, respectively. 205 
CHOLEHEPATIC SHUNT OF BILE SALTS
The cholehepatic shunt describes a transport pathway by which unconjugated dihydroxy bile salts that are secreted into the bile canaliculus are absorbed passively by cholangiocytes, returned to the hepatocyte via the 284 periductular capillary plexus, and are again secreted into bile. Absorption of the protonated bile salt molecule by the cholangiocyte produces a bicarbonate molecule, resulting in a bicarbonate-rich choleresis. 206 Because most naturally occurring bile acids are conjugated with taurine or glycine before their biliary secretion, bile acids with shortened side chains such as the C 24 dihydroxy bile acid ursodeoxycholic acid 207, 208 cause hypercholeresis when infused at rates that exceed the hepatocyte's conjugation capacity. 209 Evidence for absorption of ursodeoxycholic acid by portal bile duct cells was obtained in immunolocalization studies. 210 In rat livers infused with ursodeoxycholic acid, immunoreactivity was detected on the apical membrane of portal bile ductular cells using antibodies against ursodeoxycholic acid. Synthetic C 23 nor-and C 22 dinordihydroxy bile acids that hardly undergo conjugation are more potent inducers of hypercholeresis. 211 The nonsteroidal anti-inflammatory agent sulindac has been shown to follow the cholehepatic shunt pathway and to induce choleresis. 212 However, when coinfused with taurocholate in the isolated perfused rat liver, sulindac caused cholestasis with a reduction in taurocholate secretion. These data suggest that sulindac is secreted into the biliary tree in unconjugated form via the canalicular bile salt transport system and is subsequently passively absorbed by the bile duct epithelium, thereby inducing a bicarbonate-rich choleresis. The continuous cycling of sulindac within this cholehepatic shunt pathway leads to high local concentrations within the hepatocyte that could cause frank cholestasis by inhibition of canalicular bile salt efflux. The hepatotoxicity of sulindac in humans is well established 213 and could at least in part be explained by these mechanisms.
Next to the passive absorption of unconjugated bile acids and xenobiotics, conjugated bile salts may also undergo absorption by cholangiocytes and consequently recirculate to the hepatocyte sinusoidal membrane. The high concentrations of bile salts measured in hepatic bile would argue against a significant proportion of secreted conjugated bile salts following this route. However, the presence of the Na + -dependent IBAT protein on the apical cholangiocyte membrane suggests that intraductular absorption of conjugated bile salts occurs. Evidence in support of this hypothesis is derived from observations that exposure of isolated cholangiocytes to bile salts induces cell proliferation and increases secretin receptor gene expression and the secretin-induced cAMP response, 214 indicating a role for bile salts in modulating second messenger pathways in cholangiocytes. Bile salt uptake by cholangiocytes may also be mediated in part by Oatp3, although the exact role of this carrier in cholangiocellular bile salt transport is unknown at present. 
